Holders · period archive

CRVS · Corvus Pharmaceuticals Inc.

Q4 2020 13F holders

← latest ownership dossier

Ticker: CRVS
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares